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ABSTRACT:
Introduction: Cardiovascular disease remains the main cause of death in the world, and myocardial infarction 
represents the main contributor to this mortality. Timely restoration of myocardial blood flow with reperfusion 
therapy is crucial. Pre-hospital delay is a major obstacle for early reperfusion therapy and has negative impact on 
mortality and left ventricle function. Methods: A prospective study was carried in cardiology unit of a medical 
college from August 2013 to December 2017. Cases of acute ST segment elevation myocardial infarction that 
have undergone thrombolysis were recruited. Results: Out of 450 patients with ST Elevation Myocardial Infection 
(STEMI), delayed presentation was seen in 288 (64%) for >6 hrs and 108 (24%) patients for >12 hrs. The duration 
from onset of symptoms to the presentation in the emergency room (pre-hospital delay) was 12.66 hrs (SD=14.19, 
range = 30 min to 72 hrs). The door to needle time was 54 min (SD=24) The major factors for pre-hospital delay 
were misinterpretation of symptoms (59%) and transportation problems (31%). Conclusion: Misinterpretation of 
symptoms remain the most common cause of delayed presentation. Health education for public awareness can 
reduce the delay. Extension of thrombolytic therapy to district hospital and primary health center level after basic 
training for medical officer with checklist and collaboration in form of telemedicine with referral cardiac center may 
have major impact on morbidity and mortality reduction in acute STEMI patients with early reperfusion therapy.
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INTRODUCTION:
 Non-Communicable Disease (NCD) is a 
leading cause of death worldwide. According to the 
World Health Organization (WHO), "40 million of 
the 56 million global deaths in 2015 were due to 
NCDs". Moreover, "48% of NCDs deaths in low- 
and middle-income countries in 2015 occurred 
before the age of 70".[1] Cardiovascular disease 
remains the main cause of death worldwide, and 
myocardial infarction represents the main contributor 
to this mortality.  Annually, more than three million 
people suffer or die from ST Elevation Myocardial 
Infarction (STEMI) worldwide.[2] Treatment of 
patients with acute myocardial infarction (MI) is 
time related.[3] Delay of every minute after STEMI 
is associated with increasing mortality and morbidity.
[4] Prehospital delay is a major contributor to the 
morbidity and mortality in MI.[5] A landmark study 
by De Luca et al. showed that every 30 minutes 
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prolongation in treatment delay was associated 
with a relative risk for 1-year mortality of 1.075.
[6] Timely restoration of myocardial blood flow in 
STEMI optimizes myocardial salvage and reduces 
morbidity and mortality.[7,8] 
 Several factors contribute to pre-hospital 
delay such as age, gender, educational status, and 
clinical and psychological factors.[9] The total pre-
hospital delay period consists of two components: 
Time taken by patients to recognize that their 
symptoms are serious and to contact medical help 
(decision time) and the time taken from requesting 
help to hospital admission (home-to-hospital 
delay). Despite quality improvement efforts to 
decrease the system delay in starting reperfusion 
treatment, some percentages of patients receive 
therapy outside the recommended time interval 
even in developed countries.[10] While the extent 
and the determinants of this delay have been well 
researched in the developed countries, it remains yet 
to be systematically identified in various developing 
countries like Nepal, and Nepalese studies are few in 
this regard. This study was carried out to determine 
pre-hospital delay and associated factors in patients 
with acute STEMI.
METHODS:
 A hospital based prospective observational 
study was carried out in STEMI patients from 
August 2013 to December 2017. The study was 
conducted in cardiology unit, department of internal 
medicine, Manipal College of Medical Sciences, 
Phulbari-11, Pokhara. 
 The diagnosis of STEMI was done based on 
2013 ACC/AHA guideline and thrombolytic agents 
were given according to patient party preference 
after they were given the option of both Streptokinase 
(STK) and Tenecteplase (TNK). Thromboytic 
agents were given in patients presented within 12 
of chest pain or had clinical or electrocardiographic 
evidence of ongoing ischemia when given beyond 
12 hrs.   Hypertension was defined according to 
JNC-7 criteria , Diabetes Mellitus based on 2013 
ADA guideline and Dyslipidemia based on 2013 
ACC/AHA guideline.
 In all patients, time of delay was established 
since the onset of symptoms associated with 
myocardial infarction and the arrival to the 
emergency department whether they received 
medical care elsewhere or not. The cases of 
STEMI who were eligible for thrombolysis were 
included in this study. STEMI cases not eligible 
for thrombolysis, who had undergone primary 
angioplasty or unable to tell exact timing of chest 
pain and who presented without chest pain but 
having angina equivalent symptoms were excluded 
from the study. In all patients, clinical evolution 
follow-up was made until discharge.
 The data was collected as per the attached 
proforma. Semi structured questionnaire was used 
to interview the patient. Collected data were entered 
into a master chart prepared in Microsoft Excel 
2007 which was checked, verified and converted 
into SPSS 18 version for statistical analysis. 
Descriptive statistics like mean, percentage, 
frequency, standard deviation was used to describe 
characteristics of collected data. Chi-square was 
applied to find association between prehospital 
delay with socio-demographic characteristics and 
cardiac risk factors. P value less than 0.05 was 
considered statistically significant. 
 The study was approved by the Ethical 
Review Committee (ERC) of Manipal College of 
Medical Sciences, Nepal. The participants were 
informed about the purpose of the project, their 
right to decline participation and to withdraw at 
any stage of the study. Verbal consent was obtained 
from the participants. The confidentiality was 
maintained by removing personal identifiers and 
information was only used for purpose of the study.
RESULTS:
 Altogether 450 STEMI-diagnosed patients 
were interviewed from August 2013 to December 
2017 giving a response rate of 100%.
 Mean age of the patients was 60 yrs 
(SD=13.02). There were 319 (70.89%) male and 
131 (29.11) female patients. Mean duration of 
prehospital delay was 12.66 hrs (SD=14.19). In 
nearly one fourth of the cases, delay was more than 
12 hrs as shown in Table 1.
 Several risk factors of MI were present in 
the patients. Their frequency and percentages are 
shown in Table 2. More than 2/3rd were smoker 
and majority (52%) had hypertension.
 More than half (54.7 %, n=246) of the 
patients were treated with tenecteplase as a 
thrombolytic agent whereas 45.3% (n=204) were 
treated with streptokinase. Mean door to needle 
time was 54 minute (SD=24).
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age-group with Bonferroni correction revealed that the 
relationship was significant with the age group more than 
65 yrs. This suggests that the people above 65 yrs of age 
were more likely to be brought to hospital earlier (within 
12 hrs) as compared to other younger age groups.                       
 Table 4 shows the major factors for pre-hospital 
delay. The most common factor was misinterpretation 
of symptoms as acid peptic disease (APD) followed by 
transportation problems.
Table 1: Prehospital delay in the study population (n=450)
Duration n %
< 1 hr 3 0.67
1 to 6 hrs 159 35.33
7 to 12 hrs 180 40
>12 hrs 108 24
Table 2: Exposure of MI patients to risk factors (n = 450)
Characteristics n %
Smoking
Yes 312 69.3
No 138 30.7
Hypertension
Yes 234 52
No 216 48
Diabetes 
Mellitus
Yes 72 16
No 378 84
Dyslipidemia
Yes 72 16
No 378 84
Alcohol
Yes 102 22.7
No 348 77.3
 Association between pre-hospital delay and 
various factors is shown in Table 3. It shows that 
there was a significant association of prehospital delay 
with age-group and sex of the patient but not with 
cardiac risk factors like diabetes, hypertension, 
hypercholesterolemia, smoking, and alcohol intake. 
Further analysis of relationship between delay and 
Table 4: Factors causing pre-hospital delay (n=450)
Factors n %
Misinterpreted as APD 266 59.1
Transportation delay 140 31.1
Inter-hospital delay 31 6.9
Reperfusion decision delay 13 2.9
DISCUSSION:
 More than fifty percentage of the patients age 
ranges from 45-65 yrs with mean of 60 yrs (SD=13.02) 
which is similar to the study by Perkins-Porras L. et 
al,[11] Beig JR. et al,[12] and Ribeiro S. et al,[13] 
where mean age was 59 (SD=11.2), 57.6 (SD=10.5), 
and 62 yrs (SD=13.64) respectively. Whereas, a study 
conducted in China reported the mean age of the 
patient was  found to be 65.68 yrs (SD=12.68).[14]
Characteristics
Prehospital delay
Stats< 12.66 hrs
n (%)
≥ 12.66 hrs
n (%)
Age (yrs)
< 45 39(81.3) 9(18.8)
X2 = 6.3, df = 2
p = 0.04345 - 65 180(78.9) 48(21.1)
> 65 120(69)* 54(31)*
Sex
Female 78(60.5) 51(39.5) X2 = 21.51, df = 1
p < 0.001Male 261(81.3) 60(18.7)
Smoking habits
Yes 240(76.9) 72(23.1) X2 = 1.38, df = 1
p = 0.24No 99(71.7) 39(28.3)
Hypertension
Yes 174(74.4) 60(25.6) X2 = 0.25, df = 1
p = 0.62No 165(76.4) 51(23.6)
Diabetes
Yes 54(75.0) 18(25.0) X2 = 0.005, df = 1
p = 0.94No 285(75.4) 93(24.6)
Dyslipidemia
Yes 57(79.2) 15(20.8) X2 = 0.68, df = 1
p = 0.41No 282(74.6) 96(25.4)
* Statistically significant cell
Table 3: Association between prehospital delay and different risk factors (n = 450)
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 Nearly 1/4th (24%) of the patients duration 
of pain (prehospital delay) was >12 hrs and mean 
duration  was 12.66 hrs (SD=14.19) which is 
similar to the study from Mexico.[15] While a 
study conducted in China confirmed about the mean 
delay of 23.58 hrs (SD=85.09) which is relatively 
higher than the present study.[14] The present 
study revealed the median duration of prehospital 
delay is eight hrs which is comparatively higher 
than other studies where lesser median delay times 
were reported in Korea (2.5 hrs),[16] Beijing (2.3 
hrs),[17] and Chennai (three hrs).[18] 
 The present study highlights the door to 
needle time was 54 min (SD=24) which is comparable 
to the study from South India and Beijing which 
depicted the median door-to-needle time were 75 
and 82 min respectively.[19,20] However, few 
studies showed significantly lower door to needle 
time i.e 40 min and 34 min respectively.[12,21] 
The current study enlightened the most commonly 
used thrombolytic agent was tenecteplase (TNK) 
54.7%. Nevertheless, the study conducted in Mexico 
confirmed streptokinase as a most commonly used 
lytic agents in 67% of cases.[15] 
 Age has been shown to be a determinant of 
increased prehospital delay in many studies;[22,23] 
the present study also showed significant association 
between age-group and prehospital delay. There was 
significant association between sex of the patient 
and prehospital delay which is analogous with the 
result acquired in several studies by Ribeiro S. et 
al, Taghaddosi M. et al, Angerud KH.  et al with a 
higher proportion of female with longer pre-hospital 
delay.[13,22,23] The reason being females could not 
directly activate the transportation system and they 
had to first inform their husband or family in most 
cases and then only process of transportation started. 
While divergent result was obtained in a study by 
Banos-Gonzalez et al,[15] Farshidi H. et al,[24] and 
George L. et al,[25] where no significant association 
was found between sex and prehospital delay. 
There were no significant associations with other 
cardiac risk factors such as diabetes, hypertension, 
hypercholesterolemia, smoking habits similar to the 
study from London.[11] In contrast to this, some 
studies have reported the presence of diabetes was 
associated with increased delay.[12, 25]
 The major factors for pre-hospital delay 
were misinterpretation of symptoms (59%) 
and transportation delay (31%) due to difficult 
geographical location and non-availability of 
ambulance or other vehicles alike to the results from 
Mumbai with misinterpretation of symptoms (45%) 
and transportation problems (27%).[21] A study 
conducted in London figured out the decision time 
constituted 60% of the total pre-hospital delay period, 
home-to-hospital delay accounted for 40%.[11]
Limitations:
 This study has some limitation. Although 
every effort was made to interview patients soon 
after admission, data may have been affected by 
recall bias. We could not assess other component 
of pre-hospital delay like cardiovascular history, 
patient's attribution of symptoms, clinical and 
proximal factors, and time of admission, symptom 
onset and call for assistance. Only the cases of acute 
ST segment elevation myocardial infarction that 
have undergone thrombolysis were recruited. Only 
survivors could be interviewed thus factors that 
influenced delay in individuals who did not survive 
ACS may not have been captured. 
CONCLUSION:
 Majority of cases in our study presented out 
of window period of six hours. Misinterpretation 
of symptoms remain the most common cause of 
delayed presentation. Health education for public 
awareness can reduce the delay. Extension of 
thrombolytic therapy to district hospital and primary 
health centre level after basic training for medical 
officer with checklist and collaboration in form of 
telemedicine with referral cardiac centre may have 
major impact  on morbidity and mortality reduction 
in acute  STEMI patients with early reperfusion 
therapy.
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